Fecal transplant to ease IBS diarrhea symptoms
Treatments studied
Part of Digestive system clinical trials.
This study tests whether fecal microbiota transplantation (a stool-based treatment to change gut bacteria) can reduce symptoms of irritable bowel syndrome (IBS) that comes with diarrhea. You may be eligible if you’re an adult with diarrhea-predominant IBS and recent colonoscopy results that rule out other intestinal diseases.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and able to understand and sign consent
- Your IBS must be diarrhea-predominant (or “unclassified”) based on Rome IV criteria
- You had a colonoscopy within the last 5 years that did not find other intestinal diseases
- You should not have used antibiotics or probiotics in the last 8 weeks
- You must not have certain conditions (like Crohn’s, ulcerative colitis, celiac disease, or colon diverticular disease)
- You should not be pregnant or breastfeeding, and you must not join another experimental drug or procedure study at the same time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether transferring stool bacteria to the gut (fecal microbiota transplantation) can reduce symptoms of irritable bowel syndrome with constipation. It may help by changing the gut microbiome, but you must meet safety and health requirements.
This trial tests whether putting stool (fecal microbiota) from a donor into your bowel can improve symptoms in people with IBS who are not IBS-C. It may help by changing the gut bacteria that can influence IBS symptoms.
This study tests whether transferring stool bacteria from a healthy donor (fecal microbiota transplantation) can improve symptoms of irritable bowel syndrome (IBS). It may help by changing the gut bacteria that can influence digestion and gut discomfort.
This trial studies fecal microbiota transplantation, which is transferring stool bacteria from a healthy donor to help rebalance gut microbes. If you have irritable bowel syndrome (IBS) that hasn’t improved after several standard treatments, this study may see whether it reduces your symptoms and is safe.
This trial tests whether a fecal microbiota transplantation (FMT), which transfers healthy bacteria from a donor into your gut, can reduce severe irritable bowel syndrome (IBS) symptoms. FMT is being studied as a possible new treatment for people with IBS that hasn't improved with other treatments.
This study tests whether taking antibiotics before a fecal microbiota transplant (WMT) improves IBS symptoms. It compares how well the transplant works when patients have antibiotics beforehand versus not.
Hear when a new Irritable Bowel Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.